logo
Plus   Neg
Share
Email

Novartis Commences Tender Offer For Medicines Company

Novartis AG (NVS) said Thursday it has commenced a cash tender offer to buy all of the outstanding shares of common stock of The Medicines Co. (MDCO) for a price of $85.00 per share. The Offer will expire on January 3, 2020, unless extended.

Last month, Swiss drug major Novartis agreed to buy the Medicines Co. for $85.00 per share in cash, valuing the US-based biopharmaceutical company at about $9.7 billion. The offer price represented a premium of about 24% premium over the Medicines Company's closing share price of $68.55 on November 22, 2019.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Online-video streaming giant Netflix Inc. (NFLX), Tuesday reported a fourth-quarter profit that trounced Wall Street estimates, as revenues surged 31% driven by strong subscriber growth. Netflix added 8.76 million subscribers globally in the quarter, above its forecast of 7.60 million, to end the... Fast food chain Krystal Company has filed for bankruptcy, according to reports. The Atlanta-based Krystal filed for Chapter 11 on Sunday in the U.S. Bankruptcy Court in Atlanta. In the filing, the company reportedly disclosed assets between $10 million and $50 million, and liabilities between $50 million and $100 million. The chief executive officer of Google's parent company Alphabet called for artificial intelligence or AI to be regulated, noting that there are real concerns about the potential negative consequences of the technology. According to Alphabet CEO Sundar Pichai, there are real concerns about the negative consequences of AI, from deepfakes to nefarious uses of facial recognition.
Follow RTT
>